Royal Bank of Canada’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $0 | Buy |
190
+36
| +23% | +$81 | ﹤0.01% | 7711 |
|
|
2025
Q4 | $0 | Hold |
154
| – | – | ﹤0.01% | 7650 |
|
|
2025
Q3 | $0 | Sell |
154
-20
| -11% | -$22 | ﹤0.01% | 7539 |
|
|
2025
Q2 | $0 | Buy |
174
+20
| +13% | +$24 | ﹤0.01% | 7355 |
|
|
2025
Q1 | $0 | Hold |
154
| – | – | ﹤0.01% | 7242 |
|
|
2024
Q4 | $0 | Hold |
154
| – | – | ﹤0.01% | 7257 |
|
|
2024
Q3 | $0 | Sell |
154
-80
| -34% | -$139 | ﹤0.01% | 7458 |
|
|
2024
Q2 | $0 | Sell |
234
-283
| -55% | -$571 | ﹤0.01% | 7546 |
|
|
2024
Q1 | $1K | Buy |
517
+363
| +236% | +$840 | ﹤0.01% | 6866 |
|
|
2023
Q4 | $0 | Sell |
154
-2,540
| -94% | -$6.13K | ﹤0.01% | 7597 |
|
|
2023
Q3 | $8K | Buy |
2,694
+1,612
| +149% | +$6.1K | ﹤0.01% | 6500 |
|
|
2023
Q2 | $5K | Buy |
1,082
+460
| +74% | +$1.8K | ﹤0.01% | 6685 |
|
|
2023
Q1 | $3K | Sell |
622
-30
| -5% | -$144 | ﹤0.01% | 6713 |
|
|
2022
Q4 | $4K | Sell |
652
-459
| -41% | -$2.7K | ﹤0.01% | 6804 |
|
|
2022
Q3 | $7K | Buy |
1,111
+941
| +554% | +$7.62K | ﹤0.01% | 6615 |
|
|
2022
Q2 | $2K | Sell |
170
-15,599
| -99% | -$149K | ﹤0.01% | 7001 |
|
|
2022
Q1 | $299K | Buy |
15,769
+13,768
| +688% | +$217K | ﹤0.01% | 4729 |
|
|
2021
Q4 | $35K | Buy |
2,001
+922
| +85% | +$27.6K | ﹤0.01% | 6565 |
|
|
2021
Q3 | $40K | Buy |
1,079
+200
| +23% | +$8.88K | ﹤0.01% | 6298 |
|
|
2021
Q2 | $52K | Buy |
879
+220
| +33% | +$13.3K | ﹤0.01% | 6015 |
|
|
2021
Q1 | $43K | Buy |
659
+583
| +767% | +$45.6K | ﹤0.01% | 5990 |
|
|
2020
Q4 | $5K | Sell |
76
-187
| -71% | -$12.8K | ﹤0.01% | 6662 |
|
|
2020
Q3 | $21K | Sell |
263
-44
| -14% | -$3.51K | ﹤0.01% | 5683 |
|
|
2020
Q2 | $19K | Sell |
307
-972
| -76% | -$56.6K | ﹤0.01% | 5618 |
|
|
2020
Q1 | $67K | Buy |
1,279
+905
| +242% | +$89.7K | ﹤0.01% | 5006 |
|
|
2019
Q4 | $45K | Buy |
374
+240
| +179% | +$34.5K | ﹤0.01% | 5506 |
|
|
2019
Q3 | $24K | Sell |
134
-2
| -1% | -$282 | ﹤0.01% | 5422 |
|
|
2019
Q2 | $18K | Buy |
136
+2
| +1% | +$359 | ﹤0.01% | 5770 |
|
|
2019
Q1 | $33K | Sell |
134
-12
| -8% | -$3.17K | ﹤0.01% | 5395 |
|
|
2018
Q4 | $28K | Sell |
146
-53
| -27% | -$12.9K | ﹤0.01% | 5423 |
|
|
2018
Q3 | $66K | Buy |
199
+108
| +119% | +$33.1K | ﹤0.01% | 5090 |
|
|
2018
Q2 | $29K | Sell |
91
-322
| -78% | -$98.4K | ﹤0.01% | 5392 |
|
|
2018
Q1 | $101K | Buy |
413
+14
| +4% | +$3.93K | ﹤0.01% | 4694 |
|
|
2017
Q4 | $121K | Sell |
399
-197
| -33% | -$54.8K | ﹤0.01% | 4703 |
|
|
2017
Q3 | $158K | Buy |
596
+257
| +76% | +$74.3K | ﹤0.01% | 4685 |
|
|
2017
Q2 | $89K | Buy |
339
+280
| +475% | +$70.1K | ﹤0.01% | 4826 |
|
|
2017
Q1 | $21K | Sell |
59
-147
| -71% | -$45.5K | ﹤0.01% | 5604 |
|
|
2016
Q4 | $59K | Sell |
206
-114
| -36% | -$35.3K | ﹤0.01% | 5166 |
|
|
2016
Q3 | $109K | Hold |
320
| – | – | ﹤0.01% | 4778 |
|
|
2016
Q2 | $136K | Buy |
320
+154
| +93% | +$63.5K | ﹤0.01% | 4642 |
|
|
2016
Q1 | $53K | Buy |
166
+155
| +1,409% | +$52.9K | ﹤0.01% | 5104 |
|
|
2015
Q4 | $5K | Buy |
11
+3
| +38% | +$1.11K | ﹤0.01% | 6164 |
|
|
2015
Q3 | $2K | Sell |
8
-514
| -98% | -$183K | ﹤0.01% | 6393 |
|
|
2015
Q2 | $205K | Buy |
522
+446
| +587% | +$157K | ﹤0.01% | 4339 |
|
|
2015
Q1 | $23K | Buy |
76
+26
| +52% | +$6.35K | ﹤0.01% | 5301 |
|
|
2014
Q4 | $11K | Sell |
50
-180
| -78% | -$37.1K | ﹤0.01% | 5583 |
|
|
2014
Q3 | $53K | Buy |
230
+80
| +53% | +$20.1K | ﹤0.01% | 4919 |
|
|
2014
Q2 | $33K | Buy |
150
+123
| +456% | +$27.4K | ﹤0.01% | 5031 |
|
|
2014
Q1 | $8K | Buy |
+27
| New | +$8.6K | ﹤0.01% | 5487 |
|
|
2013
Q4 | – | Sell |
-8
| Closed | -$1K | – | 6141 |
|
|
2013
Q3 | $1K | Buy |
+8
| New | +$967 | ﹤0.01% | 5974 |
|
Other funds holding TXMD
RCMNY
CC
SCM
VCM
TC
ACM
Royal Bank of Canada's TXMD Position: Q1 2026 in Review
Royal Bank of Canada increased its TherapeuticsMD (TXMD) stake by 23% in Q1 2026, buying an estimated $81 and bringing the position to 190 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7711.
Royal Bank of Canada first reported a position in TXMD in Q3 2013 and has held it in 50 quarters since. The position peaked at $299K in Q1 2022. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.
- Royal Bank of Canada held 190 shares of TherapeuticsMD worth $0 as of Q1 2026.
- Royal Bank of Canada bought 36 TherapeuticsMD shares in Q1 2026, an estimated $81.
- TherapeuticsMD made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7711 holding.
- Royal Bank of Canada first reported a position in TherapeuticsMD in Q3 2013 and has held it in 50 quarters since.
- Royal Bank of Canada's TherapeuticsMD position peaked at $299K in Q1 2022.
- 49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.